SCPX

Healthcare Biotechnology

Scorpius Holdings, Inc.

$0.00

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

61,142.712

Avg Volume

7,967

EPS

-$4.18

52W High

$0.10

52W Low

$0.00

Div. Yield

0.0%

Valuation

Forward P/E

-0.00

P/B Ratio

-0.02

P/S Ratio

0.02

EV/EBITDA

-0.55

EV/Revenue

6.93

Margins

Gross Margin 0.0%

Operating Margin (2056.8%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

(75.1%)

Return on Equity

(303.4%)

Return on Assets

(47.9%)

Liquidity & Leverage

Current Ratio

0.10

Quick Ratio

0.07

Total Cash

600,786

Total Debt

18.12M

About

Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company serves the biotechnology and biopharmaceutical industries. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in San Antonio, Texas.